Nutritional Supplement Industry Trends: Three Waves at Vitafoods Europe 2026
—GLP-1, Women's Health, and Dosage Form Experience are Reshaping the Rules of the Game
From May 5th to 7th, 2026, the global nutritional supplement industry's attention once again focused on Barcelona. Vitafoods Europe 2026 brought together over 30,000 professionals and more than 1,600 exhibitors from 135 countries, revealing emerging industry trends: the nutritional supplement industry is shifting from "raw material-driven" to multi-dimensional competition based on "scientific evidence + demographic segmentation + experiential innovation."
Three Key Signals: Reshaping Industry Rules
Signal 1: The GLP-1 Wave is Fostering a "New Ecosystem of Nutritional Support." Over the past five years, GLP-1-related products have seen a compound annual growth rate of 124%, and the exhibition featured a full-day discussion. Several companies showcased specific solutions for GLP-1 users regarding muscle maintenance, metabolic health, and protein supplementation. The usage scenarios for nutritional supplements are being redefined.
Signal 2: Women's Health is Moving from "General Categories" to "Life Stage Refinement." The global women's health market is projected to reach $51.76 billion by 2030. Biostime Biotechnology focuses on the cross-application of microbial science and women's healthy aging, with trends shifting from "broad women's products" to "refined formulations tailored to different stages and scenarios."
Signal 3: Dosage Form Innovation Makes Nutritional Supplementation a "Daily Enjoyment." The traditional dominance of capsules and tablets is being challenged—suppliers showcased effervescent probiotic drinks, absorbable vitamin jellies, and high-protein ready-to-drink soups. For B2B clients, dosage form innovation is becoming a core competitive advantage in building product differentiation barriers.
Award-Winning Ingredient Trends: Scientific Evidence Drives Precision
The number of companies shortlisted for this year's Innovation Awards increased by 25% year-on-year, covering eight categories: sports nutrition, immune health, cognitive health, and weight management. The award list reflects the shift from an "ingredient-oriented" to a "science-driven, population-oriented" approach: Ashwa.30, an ultra-low-dose extract from Ashwa, demonstrates the trend towards "lower doses, same efficacy"; Metabolid®, a Spanish plant extract, won an award for weight management ingredients, with its mechanism of action revolving around the GLP-1 and AMPK pathways; Threotech's Magtein® (L-magnesium threonate) solves the problem of magnesium crossing the blood-brain barrier. Furthermore, Mibelle's DracoBelle™ Nu won an award in the oral beauty category, reflecting the major trend of integrating "nutrition-beauty-health".
In response to these trends, 4UNUTRA focuses on three key points:
First, the GLP-1 wave has created innovative opportunities for high-protein fortified products and multi-functional products. Our dosage form innovation platform (gummy candies, liquid oral solutions, instant powders, etc.) can quickly respond to consumer preferences for "greater convenience and greater appeal".
Secondly, facing increasingly refined niche markets (GLP-1 users, menopausal women, athletes, etc.), 4UNUTRA's 7-level customization system provides full-process support from ingredient screening and formulation development to large-scale production, helping partners shorten time-to-market.
Thirdly, the industry is returning to solid scientific capabilities. Through rigorous market data tracking and a compliance-first system, we assist clients in making informed decisions regarding ingredient selection and efficacy verification, avoiding market risks caused by non-compliant ingredients.
In short, the most exciting thing this year is that the entire industry has finally begun to wage war against "boredom." Boring dosage forms, vague target audiences, and empty ingredients—all are disappearing. More precise, enjoyable, and inclusive, the industry is ushering in a better era.